MedPath

Comparative Prospective Data Collection in Connection With Two Different Treatment Methods: Robotic Assisted Laparoscopy and Conventional Laparoscopy

Completed
Conditions
Uterine Diseases
Interventions
Procedure: laparoscopic surgery
Registration Number
NCT03861195
Lead Sponsor
University Hospital Tuebingen
Brief Summary

This is a prospective, randomized, single-center, observational clinical trial at the Department of Women's Health of the University Clinic Tübingen. Four hundred patients affected by uterine diseases that undergo treatment with robotic assisted laparoscopic procedures using the Da Vinci Robotic Surgical System (200 patients) or conventional laparoscopic surgery (200 patients) will be recruited. In addition retrospective data of 200 patients that underwent conventional laparoscopic surgery in the past will be documented. At the end of patient recruitment, surgical procedure times, the technical limits encountered, estimated blood loss, intra- and post-operative complications and the percentage of conversions from the robotic assisted treatment /conventional laparoscopic surgery to multiple access and/or to a laparotomic (open) approach will be documented.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
400
Inclusion Criteria
  • age ≥18 years
  • BMI ≤40 kg/m2
  • indication for hysterectomy for benign disease or prophylactic surgery due to hereditary cancer
  • indication for radical hysterectomy and/or pelvic-/para-aortic (sentinel-node) lymphadenectomy for cervical cancer
  • indication for modified radical hysterectomy and/or pelvic-/para-aortic (sentinel-node) lymphadenectomy for endometrial cancer
  • size of uterus and vagina allows for retrieval by the vaginal route in cancer patients
  • written informed consent
Exclusion Criteria
  • known extensive intra-abdominal adhesions
  • anaesthesiological contraindications to laparoscopy
  • women with pacemaker or other implants where electrosurgery is to be avoided
  • women with known defects of the hemostasis
  • pregnancy
  • other internal or anatomical criteria that preclude a minimal invasive approach
  • inability to understand patient information

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Da Vinci Robotic Surgical Systemlaparoscopic surgery-
conventional laparoscopic surgerylaparoscopic surgery-
Primary Outcome Measures
NameTimeMethod
console time60 minutes
German version of the Short Form-36health survey questionnaire Medical Outcomes Trust3 and 6 months

Medical Outcomes Trust: SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting.

German version of the female sexual function index (FSFI) questionnaire3 and 6 months

female sexual function index: a multidimensional self-report instrument for the assessment of female sexual function

time to discharge60 minutes
intraoperative complications60 minutes

occurring during the surgical procedure

postoperative complications6 months

occurring more than 24h after the surgical procedure up to 6 months after surgical procedure, according to the Clavien-Dindo classification of surgical complications

operative time60 minutes

(minutes from first incision to skin closure)

estimated blood loss (milliliters)60 minutes

using the following formula: ((Hemoglobin concentration preoperative (g/l)) - (Hemoglobin 1st day postoperative (g/l)))/((Hemoglobin preoperative (g/l)) - (Hemoglobin 1st day postoperative (g/l)))/2) × 1000

perioperative complications24 hours

occurring less than 24h after the surgical procedure, according to the Clavien-Dindo classification of surgical complications

time under narcosis60 minutes
conversion to other surgical procedures60 minutes
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Tuebingen, Department of Women's Health

🇩🇪

Tuebingen, Germany

© Copyright 2025. All Rights Reserved by MedPath